Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Else

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Endocrine Reviews|January 16, 2014
Adrenocortical carcinomaTobias Else, Alex C Kim, Aaron Sabolch, et al.
European Journal of Endocrinology|May 7, 2024
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiencyFelix Beuschlein, Tobias Else, Irina Bancos, et al.
BMJ Open Gastroenterology|November 9, 2021
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumoursKaren Rico, Suzann Duan, Ritu L Pandey, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2024
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal InsufficiencyFelix Beuschlein, Tobias Else, Irina Bancos, et al.
Surgery|October 23, 2018
Longitudinal patterns of recurrence in patients with adrenocortical carcinomaJason A Glenn, Tobias Else, David T Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White AmericansKazutaka Nanba, Kei Omata, Tobias Else, et al.
The Oncologist|July 22, 2024
A review of mitotane in the management of adrenocortical cancerJaydira Del Rivero, Tobias Else, Julie Hallanger-Johnson, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2020
Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing AdenomaKazutaka Nanba, Amy R Blinder, Juilee Rege, et al.
Hormones & Cancer|May 23, 2014
The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trialAntonio M Lerario, Francis P Worden, Carole A Ramm, et al.
Endocrine Reviews|May 1, 2009
In search of adrenocortical stem and progenitor cellsAlex C Kim, Ferdous M Barlaskar, Joanne H Heaton, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Endocrine Reviews|January 16, 2014
Adrenocortical carcinomaTobias Else, Alex C Kim, Aaron Sabolch, et al.
European Journal of Endocrinology|May 7, 2024
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiencyFelix Beuschlein, Tobias Else, Irina Bancos, et al.
BMJ Open Gastroenterology|November 9, 2021
Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumoursKaren Rico, Suzann Duan, Ritu L Pandey, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2024
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal InsufficiencyFelix Beuschlein, Tobias Else, Irina Bancos, et al.
Surgery|October 23, 2018
Longitudinal patterns of recurrence in patients with adrenocortical carcinomaJason A Glenn, Tobias Else, David T Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White AmericansKazutaka Nanba, Kei Omata, Tobias Else, et al.
The Oncologist|July 22, 2024
A review of mitotane in the management of adrenocortical cancerJaydira Del Rivero, Tobias Else, Julie Hallanger-Johnson, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2020
Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing AdenomaKazutaka Nanba, Amy R Blinder, Juilee Rege, et al.
Hormones & Cancer|May 23, 2014
The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trialAntonio M Lerario, Francis P Worden, Carole A Ramm, et al.
Endocrine Reviews|May 1, 2009
In search of adrenocortical stem and progenitor cellsAlex C Kim, Ferdous M Barlaskar, Joanne H Heaton, et al.
Pageof 14